Alice Williams, MS, LBSW, Manager, Communications & Community Initiatives leads community engagement efforts, including:
- Frequent presentations
to community groups about
current research and opportunities to participate
- Collaboration with the Alzheimer's Association and facilitation of the Caregiver Connection support group
- Facilitation of the Community Advisory Board (CAB).
- Health education for older adults via Patient Education Programs (PEP) and the National Diabetes Prevention Program lifestyle change program (PreventT2®).
- Recruitment of older adults for the Stories of Aging initiative.
- Support of the annual Seaside Senior Expo
The CAB plays an important role in strengthening partnerships between research and the community. Meeting every three months, the CAB is co‑chaired by Rebecca Galloway, PhD, PT, GCS, CEEAA, and Alice Williams, MS, LBSW, who help guide the group’s work and conversations.
The CAB serves as a welcoming space where patients, caregivers, and community members can share their experiences and perspectives to help shape OAIC research. By listening to and learning from the community, the Board helps researchers better understand what matters most to older adults and those who support them.
CAB members offer valuable input on developing new research ideas.
Membership includes older adults with personal or caregiver experience, as well as individuals active in faith communities, local nursing homes, home health organizations, hospitals, and senior centers. Together, they help ensure that research remains connected to the real needs of the community.
In 2022, SCOA launched the Community Connection initiative to share research findings, educational content, and volunteer opportunities with older adults in the Galveston County area. This project includes a quarterly newsletter, distributed via email and traditional mail, which has grown to over 1,400 subscribers. The newsletter aims to boost engagement by highlighting SCOA researchers and offering opportunities to participate in aging-related clinical studies at UTMB.